Saturday - December 21, 2024

Guide RNA That Targets a Mutant Human Guanylate Cyclase 2A Allele

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- EMENDOBIO INC., Wilmington, Delaware has been assigned a patent (No. US 12168062 B2, initially filed Nov. 28, 2018) developed by six inventors Lior Izhar, Tel Aviv, Israel; David Baram, Nir Zvi, Israel; Joe Georgeson, Rehevot, Israel; Michal Golan-Mashiach, Ness-Ziona, Israel; Asael Herman, Ness-Ziona, Israel; and Rafi Emmanuel, Ramla, Israel, for "Guide RNA that targets a mutant human guanylate cyclase 2A allele." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Guide RNA That Targets a Mutant Human Guanylate Cyclase 2A Allele

Information Request Form

Copyright Targeted News Service 2024